Cocrystal Pharma Inc develops novel medicines for the treatment of human viral diseases. It focuses on the development and commercialization of broad-spectrum antiviral drug candidates that transforms the treatment and prophylaxis of diseases in humans.
$0.42 +0.02 (6.36%)
As of 05/26/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.